zhiyong chen

Zhiyong Chen has a strong background in biosciences and pharmaceutical research. zhiyong started their career as a research scientist at Trius Therapeutics Inc. in 2007, where they worked until 2014. In 2014, they joined Crinetics Pharmaceuticals as a Senior Research Scientist, and later that same year, they moved to Cidara Therapeutics as a Principal Scientist. Most recently, in 2019, Zhiyong joined Kumquat Biosciences Inc. in the role of Principal Scientist. Throughout their career, Zhiyong has demonstrated their expertise in the field and has contributed to the development of innovative pharmaceutical solutions.

Zhiyong Chen's education history indicates that they pursued a Doctor of Philosophy (Ph.D.) degree in the field of total synthesis of Natural Products from The University of Hong Kong. zhiyong studied at this institution from 1999 to 2002. After that, Zhiyong Chen undertook further education in the field of Biochemistry and Molecular Biology at Scripps Research from 2004 to 2007. The degree obtained from Scripps Research is unavailable.